Related Experiment Video
Updated: Mar 29, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
Association Between ACE (I/D) Polymorphism and Essential Hypertension (EH): An Updated Systematic Review and
Athina Smallwood1, Elizabeth Akam1, David John Hunter1
1School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough LE11 3TU, UK.
Background:
Essential hypertension (EH) refers to elevated arterial blood pressure with unknown etiology, which becomes more prevalent with age. Although the D allele of the ACE (I/D) polymorphism has been linked to EH, this association is not consistent across global populations. This systematic review and meta-analysis examined the relationship between the ACE (I/D) polymorphism and EH in diverse populations to determine the comparability of effect sizes and explore potential implications for public health planning.
Methods:
Case-control and cohort studies published in the last 20 years were reviewed from the main databases (PubMed, Scopus and Embase) using specific inclusion and exclusion criteria. Genotype data were used in meta-analyses using different genetic models.
Results:
Twenty-two studies with 7690 participants (3886 cases and 3804 controls) were included. Significant associations were observed between the ACE D allele and EH across allelic (OR = 1.37, 95% CI: 1.14-1.63), recessive (OR = 1.61, 95% CI: 1.21-2.13), dominant (OR = 1.37, 95% CI: 1.13-1.67), and homozygote (OR = 1.79, 95% CI: 1.31-2.45) models. Subgroup analyses showed significant associations in Indian and European populations, while African, Middle Eastern and Hispanic groups showed no statistically significant associations.
Conclusions:
The findings support a significant association between the ACE D allele and EH in several populations, though associations vary by ethnicity.
More Related Videos
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hypertension II: Pathophysiology
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure

